STOCK TITAN

Medpace (NASDAQ: MEDP) director plans 3,858-share sale after option exercise

(Neutral)
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Medpace Holdings, Inc. (MEDP) received a notice under Rule 144 that director Robert O. Kraft plans to sell restricted common stock. The planned sale covers 3,858 shares of common stock through Fidelity Brokerage Services LLC on or about August 26, 2026, in connection with a stock option exercise. The shares are listed on NASDAQ. The notice is signed on Kraft’s behalf by Fidelity as attorney-in-fact.

Positive

  • None.

Negative

  • None.
Shares to be sold 3,858 shares of common stock Planned Rule 144 sale related to stock option exercise
Aggregate market value 2,383,522.47 Aggregate market value of 3,858 shares to be sold
Shares outstanding 27,911,655 shares Number of common shares outstanding referenced in the notice
Approximate sale date 08/26/2026 Planned date for Rule 144 sale
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
aggregate market value financial
"Common | Fidelity Brokerage Services LLC ... | 2383522.47 | 27911655 |"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
stock option exercise financial
"Common | 08/26/2026 | Stock Option Exercise | Issuer"
A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.
attorney-in-fact regulatory
"as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Robert O. Kraft"
An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

What does the Form 144 filing disclose for Medpace Holdings, Inc. (MEDP)?

The filing discloses that director Robert O. Kraft intends to sell 3,858 shares of Medpace Holdings, Inc. common stock under Rule 144, in connection with a stock option exercise, through Fidelity Brokerage Services LLC, with an expected sale date of August 26, 2026.

How many MEDP shares are covered by Robert O. Kraft’s planned Rule 144 sale?

Robert O. Kraft’s planned Rule 144 transaction covers 3,858 shares of Medpace Holdings, Inc. common stock, to be sold in connection with a stock option exercise through Fidelity Brokerage Services LLC.

What is the aggregate market value reported for the MEDP shares in this Form 144?

The notice reports an aggregate market value of 2,383,522.47 for the 3,858 shares of Medpace Holdings, Inc. common stock subject to the planned Rule 144 sale.

When is the planned sale of Medpace (MEDP) shares expected to occur under this Form 144?

The planned Rule 144 sale of 3,858 MEDP shares related to a stock option exercise is indicated to occur on or about August 26, 2026.

Who is executing the planned Form 144 sale for Medpace (MEDP) director Robert O. Kraft?

The planned sale will be executed through Fidelity Brokerage Services LLC. The Form 144 is signed by Daniel Tucci as a duly authorized representative of Fidelity, acting as attorney-in-fact for Robert O. Kraft.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature